NDC 39822-2100
dactinomycin
Dactinomycin
dactinomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by X-gen Pharmaceuticals, Inc.. The primary component is Dactinomycin.
| Product ID | 39822-2100_0889a20b-658e-4dba-a2e7-65c8b2e5a229 |
| NDC | 39822-2100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | dactinomycin |
| Generic Name | Dactinomycin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-07-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203999 |
| Labeler Name | X-GEN Pharmaceuticals, Inc. |
| Substance Name | DACTINOMYCIN |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |